Análisis de la acción Celsius Holdings, Inc. (CELH)CELHCelsius Holdings, Inc.

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu. It operates in the Consumer Non-Cyclicals sector (BOTTLED & CANNED SOFT DRINKS & CARBONATED WATERS industry).

Celsius Holdings Inc is currently a hold due to mixed signals in its performance and analyst outlook. The current price is $32.98, and while Goldman Sachs has a bullish target of $45, Deutsche Bank has downgraded it to Hold with a target of $35, reflecting concerns about the company's recent earnings miss and delayed recovery expectations. The RSI is at 54.103, indicating a neutral momentum, and the stock has seen a significant year-to-date decline of 30.93%. The main risk is the recent downgrade from Deutsche Bank, which suggests that the stock may not recover in the near term, while the potential upside remains limited until the company shows clearer signs of recovery.

1 analysts cover CELH: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 62.85.